Kraig Biocraft Laboratories, Inc. (KBLB) — SEC Financial Statements & Analysis

Kraig Biocraft Laboratories, Inc. (KBLB) is a plastic material, synth resin/rubber, cellulos (no glass) company, incorporated in WY. Kraig Biocraft Laboratories, Inc. trades on OTC as: KBLB. Kraig Biocraft Laboratories, Inc. (KBLB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Kraig Biocraft Laboratories, Inc. carries a market cap of $111.03M, a P/E ratio of -26.76x, a P/B ratio of -16.45x, a P/S ratio of 3435.04x, an enterprise value of $107.64M, and an EV/EBITDA multiple of -29.42x. On profitability, it posts an operating margin of -11301.04%, a net margin of -12493.34%, a Return on Equity (ROE) of 54.51%, and a Return on Assets (ROA) of -141.54%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $-0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 58.92% year-over-year, and EPS growth of 49.92% year-over-year. On the balance sheet, it maintains a current ratio of 0.33x, a quick ratio of 0.31x, working capital of $-7.33M, a debt-to-equity ratio of -1.63x, a debt ratio of 2.58, an interest coverage ratio of -6.27x, free cash flow of $-2.08M (TTM), and net debt of $-3.39M. Figures sourced from SEC EDGAR.

Market Cap

$111.03M

P/E TTM

-26.76x

EPS TTM

$-0.00

P/B TTM

-16.45x

ROE TTM

54.51%

ROA TTM

-141.54%

Debt To Equity

-1.63x

Free Cash Flow TTM

$-2.08M

Net Revenue TTM Growth 1Y

-100.00%

Data as of 2026-06-30 · Source: SEC EDGAR